Unknown

Dataset Information

0

Transcriptome profiles acquired during cell expansion and licensing validate mesenchymal stromal cell lineage genes.


ABSTRACT: BACKGROUND:Mesenchymal stromal cells (MSCs) are rapidly advancing as commercial therapeutics. However, there are still no adequate tools to validate the identity of MSCs and support standardization of MSC-based products. Currently accepted metrics include cell surface marker profiling and tri-lineage differentiation assays, neither of which is definitive. Transcript profiling represents a cost- and time-effective approach amenable to MSC manufacturing processes. Two independent labs recently reported non-overlapping MSC-specific transcriptomic signatures of 489 and 16 genes. METHODS:Here, we interrogated our repository of transcriptome data to determine whether routine culture manipulations including cell expansion and immune activation affect expression of the reported MSC lineage genes. These data sets comprise 4 donor populations of human umbilical cord (UC) MSCs serially cultured from cryopreservation thaw through pre-senescence, and 3 donor populations each of naïve UC and bone marrow (BM) MSCs and licensed by 3 different cytokines. RESULTS:Overall, 437 of 456 proposed signature genes assessed in these data sets were reliably expressed, representing an enduring lineage profile in 96% agreement with the previous studies. Serial passaging resulted in the downregulation of 3 signature genes, and one was silenced. Cytokine stimulation downregulated expression of 16 signature genes, and 3 were uniformly silenced in one or the other MSC type. Fifteen additional genes were unreliably detected, independent of culture manipulation. CONCLUSION:These results validate and refine the proposed transcriptomic tools for reliable identification of MSCs after isolation through cell expansion and after inflammatory activation. We propose a 24-gene signature to support standardized and accessible MSC characterization.

SUBMITTER: Wiese DM 

PROVIDER: S-EPMC7427746 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Transcriptome profiles acquired during cell expansion and licensing validate mesenchymal stromal cell lineage genes.

Wiese Danielle M DM   Braid Lorena R LR  

Stem cell research & therapy 20200814 1


<h4>Background</h4>Mesenchymal stromal cells (MSCs) are rapidly advancing as commercial therapeutics. However, there are still no adequate tools to validate the identity of MSCs and support standardization of MSC-based products. Currently accepted metrics include cell surface marker profiling and tri-lineage differentiation assays, neither of which is definitive. Transcript profiling represents a cost- and time-effective approach amenable to MSC manufacturing processes. Two independent labs rece  ...[more]

Similar Datasets

| S-EPMC9297916 | biostudies-literature
| S-EPMC7324175 | biostudies-literature
2019-05-31 | GSE115149 | GEO
| S-EPMC6766122 | biostudies-literature
| S-EPMC7044478 | biostudies-literature
| S-EPMC5511371 | biostudies-literature